United Kingdom
Add to My Companies | Give a Referral for this Company | Print this ProfileThe latest news, announcements and press releases from ViaNautis Bio.
Cambridge, UK, 28 October, 2024 – ViaNautis Bio ("ViaNautis" or the "Company"), a groundbreaking biotechnology company at the forefront of delivering targeted genetic nanomedicines, today announces a collaboration with Eli Lilly and Company (“Lilly”).
Under the terms of the agreement, ViaNautis will receive an initial upfront payment from Lilly, with the short-term potential for additional payments including research-based milestones. Further milestones and royalties would be due should specific cargo-loaded polyNaut®-based products enter the clinic and reach commercialisation. This collaboration will leverage ViaNautis’ platform for precise delivery of genetic cargos to prioritised tissues to address significant unmet medical needs.
This is the News section of the company profile page for ViaNautis Bio on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
